Raynaud’s Relief

Sildenafil (Viagra) Reduces Raynaud’s Frequency in Patients with Scleroderma

    Modified-Release Therapy is Well Tolerated in Clinical Trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The […]